Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Cayman Chemical Company Expands Pittsfield Township, Michigan, Facilities

12/26/2018
Cayman Chemical Company, Inc., headquartered in Ann Arbor, plans to expand its manufacturing complex in Pittsfield Township, Michigan.

The company supplies scientists worldwide with the resources necessary for advancing human and animal health in research and the development of medicines.

According to the Michigan Economic Development Corporation, Cayman manufactures high-quality biochemicals, assay kits, antibodies and recombinant proteins, active pharmaceutical ingredients, and forensic reference standards for drugs of abuse. Cayman also offers contract services for custom chemical synthesis and analysis, assay development and screening, and drug discovery.

State officials said Cayman is experiencing significant growth and has outgrown its current facilities. The company plans to expand its existing facilities in Pittsfield Township to create additional manufacturing laboratory space for biochemicals and active pharmaceutical ingredients, as well as expanding its research and development labs.

The project is expected to generate total private investment of $10 million and create 80 high-paying jobs, resulting in a $720,000 Michigan Business Development Program performance-based grant, MEDC said.

“We look forward to working with Cayman Chemical as the company brings new talent to the region and continues to expand its research and development capabilities in Pittsfield Township,” said Paul Krutko, President & CEO of Ann Arbor SPARK. “Cayman Chemical’s industry leading R&D pharmaceutical development work puts this region on the map for biotech. It’s exciting the company’s growth will continue to fuel the strength of our biotech ecosystem.”

Exclusive Research